Orasis Pharmaceuticals
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 Marketside Ave Ste 404-324, Ponte Ve...Website
www.orasis-pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Orasis Pharmaceuticals
Orasis Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orasis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Orasis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Orasis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Orasis Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Orasis Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Orasis Pharmaceuticals
Check out if Orasis Pharmaceuticals is spiking on competitors!
Click to see if Orasis Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Orasis Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Orasis Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Orasis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orasis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orasis Pharmaceuticals.
Orasis Pharmaceuticals financials insights
Gather financial insights about Orasis Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$13M
Series C
$30M
Debt
$15M
Series D
$68M
Orasis Pharmaceuticals Tech Stack
A closer look at the technologies used by Orasis Pharmaceuticals
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orasis Pharmaceuticals
Orasis is an emerging ophthalmic pharmaceutical company with an FDA approved prescription eye drop, QLOSI, for presbyopia as an alternative to reading glasses.... Read More
